Clinical Trial Update: MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating MK2461 in patients with advanced cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MK2461

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED